| ||
Pacira says pain drug Exparel fails in new study Businessweek NEW YORK (AP) — Pacira Pharmaceuticals Inc. said Thursday its surgical pain drug Exparel failed in a late-stage clinical trial, and its shares slumped 10 percent in after-hours trading. The trial was designed to evaluate Exparel for use in blocking ... See all stories on this topic » | ||
Cardinal Health takes loss on $829M write-down Businessweek DUBLIN, Ohio (AP) — Prescription drug distributor Cardinal Health Inc. said Thursday that it took a loss in its fiscal fourth quarter after writing down the value of its nuclear pharmacy business by $829 million. Despite the charge, the company's ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment